BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID of Ligand PubChem SID of Ligand ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence PDB ID(s) of Target Chain UniProt (SwissProt) Recommended Name of Target Chain UniProt (SwissProt) Entry Name of Target Chain UniProt (SwissProt) Primary ID of Target Chain UniProt (SwissProt) Secondary ID(s) of Target Chain UniProt (SwissProt) Alternative ID(s) of Target Chain UniProt (TrEMBL) Submitted Name of Target Chain UniProt (TrEMBL) Entry Name of Target Chain UniProt (TrEMBL) Primary ID of Target Chain UniProt (TrEMBL) Secondary ID(s) of Target Chain UniProt (TrEMBL) Alternative ID(s) of Target Chain 708263 O=C(NCc1ccccc1)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C25H22N6O3/c32-25(28-15-17-4-2-1-3-5-17)19-6-7-23-27-16-20(31(23)29-19)22-14-18-21(34-22)8-9-26-24(18)30-10-12-33-13-11-30/h1-9,14,16H,10-13,15H2,(H,28,32) WYBMLHRFXSOJGY-UHFFFAOYSA-N 358852 N-benzyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 4.40 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358852&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118227019 386398359 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708264 COCCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C22H24N6O4/c1-30-10-2-6-24-22(29)16-3-4-20-25-14-17(28(20)26-16)19-13-15-18(32-19)5-7-23-21(15)27-8-11-31-12-9-27/h3-5,7,13-14H,2,6,8-12H2,1H3,(H,24,29) MEENFNJMJCZNBC-UHFFFAOYSA-N 358853 N-(3-methoxypropyl)-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 3.80 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358853&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226887 386398360 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708265 CN(C)CCN(C)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H27N7O3/c1-27(2)8-9-28(3)23(31)17-4-5-21-25-15-18(30(21)26-17)20-14-16-19(33-20)6-7-24-22(16)29-10-12-32-13-11-29/h4-7,14-15H,8-13H2,1-3H3 FOYUODPUQZERHM-UHFFFAOYSA-N 358854 N-[2-(dimethylamino)ethyl]-N-methyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 88.0 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358854&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226896 386398361 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708266 CN1CCN(CC1)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H25N7O3/c1-27-6-8-29(9-7-27)23(31)17-2-3-21-25-15-18(30(21)26-17)20-14-16-19(33-20)4-5-24-22(16)28-10-12-32-13-11-28/h2-5,14-15H,6-13H2,1H3 GRIUCHRPBVVMKI-UHFFFAOYSA-N 358855 (4-Methylpiperazin-1-yl){3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo-[1,2-b]pyridazin-6-yl}methanone::US10214545, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 110 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358855&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226953 386398362 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708267 COCCN(C)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C22H24N6O4/c1-26(7-10-30-2)22(29)16-3-4-20-24-14-17(28(20)25-16)19-13-15-18(32-19)5-6-23-21(15)27-8-11-31-12-9-27/h3-6,13-14H,7-12H2,1-2H3 VOMKYFREVRKVTK-UHFFFAOYSA-N 358856 N-(2-methoxyethyl)-N-methyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 2.60 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358856&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226955 386398363 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708268 COCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-29-9-6-23-21(28)15-2-3-19-24-13-16(27(19)25-15)18-12-14-17(31-18)4-5-22-20(14)26-7-10-30-11-8-26/h2-5,12-13H,6-11H2,1H3,(H,23,28) WGGGLERYINLRRP-UHFFFAOYSA-N 358857 N-(2-methoxyethyl)-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 4.60 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358857&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226869 386398364 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708269 C[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-13(12-28)24-21(29)15-2-3-19-23-11-16(27(19)25-15)18-10-14-17(31-18)4-5-22-20(14)26-6-8-30-9-7-26/h2-5,10-11,13,28H,6-9,12H2,1H3,(H,24,29)/t13-/m1/s1 PVRBWFBXZIVHES-CYBMUJFWSA-N 358858 N-[(2R)-1-hydroxypropan-2-yl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 2.80 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358858&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126506660 386398365 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708270 C[C@@H](CO)NC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-13(12-28)24-21(29)15-2-3-19-23-11-16(27(19)25-15)18-10-14-17(31-18)4-5-22-20(14)26-6-8-30-9-7-26/h2-5,10-11,13,28H,6-9,12H2,1H3,(H,24,29)/t13-/m0/s1 PVRBWFBXZIVHES-ZDUSSCGKSA-N 358859 N-[(2S)-1-hydroxypropan-2-yl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 7.30 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358859&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226928 386398366 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708271 CN(C)CCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H27N7O3/c1-28(2)9-3-7-25-23(31)17-4-5-21-26-15-18(30(21)27-17)20-14-16-19(33-20)6-8-24-22(16)29-10-12-32-13-11-29/h4-6,8,14-15H,3,7,9-13H2,1-2H3,(H,25,31) XANSVPHMOYWUDL-UHFFFAOYSA-N 358860 N-[3-(dimethylamino)propyl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 1.50 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358860&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226903 386398367 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708272 CN(C)CCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H21N5O2/c1-24(2)11-5-10-21-20(26)15-8-9-19-22-13-16(25(19)23-15)18-12-14-6-3-4-7-17(14)27-18/h3-4,6-9,12-13H,5,10-11H2,1-2H3,(H,21,26) DDJUFZKSGQXYOQ-UHFFFAOYSA-N 358861 3-(1-Benzofuran-2-yl)-N-[3-(dimethylamino)propyl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 3.30 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358861&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226974 386398368 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708273 C[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O3/c1-11(10-23)20-18(24)13-6-7-17-19-9-14(22(17)21-13)16-8-12-4-2-3-5-15(12)25-16/h2-9,11,23H,10H2,1H3,(H,20,24)/t11-/m1/s1 CCGWYSCQCABNRE-LLVKDONJSA-N 358862 3-(1-Benzofuran-2-yl)-N-[(2R)-1-hydroxypropan-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 4.10 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358862&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126506376 386398369 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708274 COCCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O3/c1-25-10-4-9-20-19(24)14-7-8-18-21-12-15(23(18)22-14)17-11-13-5-2-3-6-16(13)26-17/h2-3,5-8,11-12H,4,9-10H2,1H3,(H,20,24) OGCODLLIZHFTLY-UHFFFAOYSA-N 358863 3-(1-Benzofuran-2-yl)-N-(3-methoxypropyl)imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 4.90 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358863&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226876 386398370 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708275 CC(C)[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-12(2)15(11-25)22-20(26)14-7-8-19-21-10-16(24(19)23-14)18-9-13-5-3-4-6-17(13)27-18/h3-10,12,15,25H,11H2,1-2H3,(H,22,26)/t15-/m0/s1 HQISLAYJOPDUTK-HNNXBMFYSA-N 358864 3-(1-Benzofuran-2-yl)-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]imidazo[1,2-b]-pyridazine-6-carboxamide::US10214545, Example 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 6.80 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358864&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126505992 386398371 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708276 O=C(NCc1ccccc1)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H16N4O2/c27-22(24-13-15-6-2-1-3-7-15)17-10-11-21-23-14-18(26(21)25-17)20-12-16-8-4-5-9-19(16)28-20/h1-12,14H,13H2,(H,24,27) OIHQAKBAJBCIMS-UHFFFAOYSA-N 358865 3-(1-Benzofuran-2-yl)-N-benzylimidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 5.20 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358865&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226966 386398372 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708277 COCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O3/c1-24-9-8-19-18(23)13-6-7-17-20-11-14(22(17)21-13)16-10-12-4-2-3-5-15(12)25-16/h2-7,10-11H,8-9H2,1H3,(H,19,23) OLVXJFKWUNVLLV-UHFFFAOYSA-N 358866 3-(1-Benzofuran-2-yl)-N-(2-methoxyethyl)imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 8.00 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358866&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226981 386398373 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708278 CN(Cc1ccccc1)C(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H18N4O2/c1-26(15-16-7-3-2-4-8-16)23(28)18-11-12-22-24-14-19(27(22)25-18)21-13-17-9-5-6-10-20(17)29-21/h2-14H,15H2,1H3 MOSBOQYSPFXZQT-UHFFFAOYSA-N 358867 3-(1-Benzofuran-2-yl)-N-benzyl-N-methylimidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 8.80 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358867&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226949 386398374 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708279 CN(C)CCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H19N5O2/c1-23(2)10-9-20-19(25)14-7-8-18-21-12-15(24(18)22-14)17-11-13-5-3-4-6-16(13)26-17/h3-8,11-12H,9-10H2,1-2H3,(H,20,25) JAFJCFZVEUTXGQ-UHFFFAOYSA-N 358868 3-(1-Benzofuran-2-yl)-N-[2-(dimethylamino)ethyl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 1.70 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358868&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226871 386398375 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708280 CC(C)[C@@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-12(2)15(11-25)22-20(26)14-7-8-19-21-10-16(24(19)23-14)18-9-13-5-3-4-6-17(13)27-18/h3-10,12,15,25H,11H2,1-2H3,(H,22,26)/t15-/m1/s1 HQISLAYJOPDUTK-OAHLLOKOSA-N 358869 3-(1-Benzofuran-2-yl)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]imidazo[1,2-b]-pyridazine-6-carboxamide::US10214545, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 1.30 US Patent 10.7270/Q2833V9N aid1797726 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358869&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 91824175 386398376 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708281 O=C(NCc1ccccc1)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C25H22N6O3/c32-25(28-15-17-4-2-1-3-5-17)19-6-7-23-27-16-20(31(23)29-19)22-14-18-21(34-22)8-9-26-24(18)30-10-12-33-13-11-30/h1-9,14,16H,10-13,15H2,(H,28,32) WYBMLHRFXSOJGY-UHFFFAOYSA-N 358852 N-benzyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 1 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 5.60 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358852&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118227019 386398359 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708282 COCCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C22H24N6O4/c1-30-10-2-6-24-22(29)16-3-4-20-25-14-17(28(20)26-16)19-13-15-18(32-19)5-7-23-21(15)27-8-11-31-12-9-27/h3-5,7,13-14H,2,6,8-12H2,1H3,(H,24,29) MEENFNJMJCZNBC-UHFFFAOYSA-N 358853 N-(3-methoxypropyl)-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 2 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 7.00 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358853&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226887 386398360 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708283 CN(C)CCN(C)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H27N7O3/c1-27(2)8-9-28(3)23(31)17-4-5-21-25-15-18(30(21)26-17)20-14-16-19(33-20)6-7-24-22(16)29-10-12-32-13-11-29/h4-7,14-15H,8-13H2,1-3H3 FOYUODPUQZERHM-UHFFFAOYSA-N 358854 N-[2-(dimethylamino)ethyl]-N-methyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 3 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 140 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358854&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226896 386398361 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708284 CN1CCN(CC1)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H25N7O3/c1-27-6-8-29(9-7-27)23(31)17-2-3-21-25-15-18(30(21)26-17)20-14-16-19(33-20)4-5-24-22(16)28-10-12-32-13-11-28/h2-5,14-15H,6-13H2,1H3 GRIUCHRPBVVMKI-UHFFFAOYSA-N 358855 (4-Methylpiperazin-1-yl){3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo-[1,2-b]pyridazin-6-yl}methanone::US10214545, Example 4 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 280 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358855&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226953 386398362 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708285 COCCN(C)C(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C22H24N6O4/c1-26(7-10-30-2)22(29)16-3-4-20-24-14-17(28(20)25-16)19-13-15-18(32-19)5-6-23-21(15)27-8-11-31-12-9-27/h3-6,13-14H,7-12H2,1-2H3 VOMKYFREVRKVTK-UHFFFAOYSA-N 358856 N-(2-methoxyethyl)-N-methyl-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 5 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 8.70 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358856&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226955 386398363 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708286 COCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-29-9-6-23-21(28)15-2-3-19-24-13-16(27(19)25-15)18-12-14-17(31-18)4-5-22-20(14)26-7-10-30-11-8-26/h2-5,12-13H,6-11H2,1H3,(H,23,28) WGGGLERYINLRRP-UHFFFAOYSA-N 358857 N-(2-methoxyethyl)-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 6 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 12.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358857&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226869 386398364 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708287 C[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-13(12-28)24-21(29)15-2-3-19-23-11-16(27(19)25-15)18-10-14-17(31-18)4-5-22-20(14)26-6-8-30-9-7-26/h2-5,10-11,13,28H,6-9,12H2,1H3,(H,24,29)/t13-/m1/s1 PVRBWFBXZIVHES-CYBMUJFWSA-N 358858 N-[(2R)-1-hydroxypropan-2-yl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 7 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 5.80 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358858&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126506660 386398365 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708288 C[C@@H](CO)NC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C21H22N6O4/c1-13(12-28)24-21(29)15-2-3-19-23-11-16(27(19)25-15)18-10-14-17(31-18)4-5-22-20(14)26-6-8-30-9-7-26/h2-5,10-11,13,28H,6-9,12H2,1H3,(H,24,29)/t13-/m0/s1 PVRBWFBXZIVHES-ZDUSSCGKSA-N 358859 N-[(2S)-1-hydroxypropan-2-yl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 8 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 21.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358859&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226928 386398366 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708289 CN(C)CCCNC(=O)c1ccc2ncc(-c3cc4c(nccc4o3)N3CCOCC3)n2n1 InChI=1S/C23H27N7O3/c1-28(2)9-3-7-25-23(31)17-4-5-21-26-15-18(30(21)27-17)20-14-16-19(33-20)6-8-24-22(16)29-10-12-32-13-11-29/h4-6,8,14-15H,3,7,9-13H2,1-2H3,(H,25,31) XANSVPHMOYWUDL-UHFFFAOYSA-N 358860 N-[3-(dimethylamino)propyl]-3-[4-(morpholin-4-yl)furo[3,2-c]pyridin-2-yl]-imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 9 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 4.50 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358860&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226903 386398367 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708290 CN(C)CCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H21N5O2/c1-24(2)11-5-10-21-20(26)15-8-9-19-22-13-16(25(19)23-15)18-12-14-6-3-4-7-17(14)27-18/h3-4,6-9,12-13H,5,10-11H2,1-2H3,(H,21,26) DDJUFZKSGQXYOQ-UHFFFAOYSA-N 358861 3-(1-Benzofuran-2-yl)-N-[3-(dimethylamino)propyl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 10 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 7.90 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358861&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226974 386398368 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708291 C[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O3/c1-11(10-23)20-18(24)13-6-7-17-19-9-14(22(17)21-13)16-8-12-4-2-3-5-15(12)25-16/h2-9,11,23H,10H2,1H3,(H,20,24)/t11-/m1/s1 CCGWYSCQCABNRE-LLVKDONJSA-N 358862 3-(1-Benzofuran-2-yl)-N-[(2R)-1-hydroxypropan-2-yl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 11 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 8.80 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358862&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126506376 386398369 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708292 COCCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H18N4O3/c1-25-10-4-9-20-19(24)14-7-8-18-21-12-15(23(18)22-14)17-11-13-5-2-3-6-16(13)26-17/h2-3,5-8,11-12H,4,9-10H2,1H3,(H,20,24) OGCODLLIZHFTLY-UHFFFAOYSA-N 358863 3-(1-Benzofuran-2-yl)-N-(3-methoxypropyl)imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 12 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 9.50 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358863&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226876 386398370 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708293 CC(C)[C@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-12(2)15(11-25)22-20(26)14-7-8-19-21-10-16(24(19)23-14)18-9-13-5-3-4-6-17(13)27-18/h3-10,12,15,25H,11H2,1-2H3,(H,22,26)/t15-/m0/s1 HQISLAYJOPDUTK-HNNXBMFYSA-N 358864 3-(1-Benzofuran-2-yl)-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]imidazo[1,2-b]-pyridazine-6-carboxamide::US10214545, Example 13 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 12.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358864&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 126505992 386398371 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708294 O=C(NCc1ccccc1)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C22H16N4O2/c27-22(24-13-15-6-2-1-3-7-15)17-10-11-21-23-14-18(26(21)25-17)20-12-16-8-4-5-9-19(16)28-20/h1-12,14H,13H2,(H,24,27) OIHQAKBAJBCIMS-UHFFFAOYSA-N 358865 3-(1-Benzofuran-2-yl)-N-benzylimidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 14 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 12.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358865&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226966 386398372 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708295 COCCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C18H16N4O3/c1-24-9-8-19-18(23)13-6-7-17-20-11-14(22(17)21-13)16-10-12-4-2-3-5-15(12)25-16/h2-7,10-11H,8-9H2,1H3,(H,19,23) OLVXJFKWUNVLLV-UHFFFAOYSA-N 358866 3-(1-Benzofuran-2-yl)-N-(2-methoxyethyl)imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 15 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 15.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358866&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226981 386398373 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708296 CN(Cc1ccccc1)C(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C23H18N4O2/c1-26(15-16-7-3-2-4-8-16)23(28)18-11-12-22-24-14-19(27(22)25-18)21-13-17-9-5-6-10-20(17)29-21/h2-14H,15H2,1H3 MOSBOQYSPFXZQT-UHFFFAOYSA-N 358867 3-(1-Benzofuran-2-yl)-N-benzyl-N-methylimidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 16 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 23.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358867&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226949 386398374 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708297 CN(C)CCNC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C19H19N5O2/c1-23(2)10-9-20-19(25)14-7-8-18-21-12-15(24(18)22-14)17-11-13-5-3-4-6-16(13)26-17/h3-8,11-12H,9-10H2,1-2H3,(H,20,25) JAFJCFZVEUTXGQ-UHFFFAOYSA-N 358868 3-(1-Benzofuran-2-yl)-N-[2-(dimethylamino)ethyl]imidazo[1,2-b]pyridazine-6-carboxamide::US10214545, Example 17 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 34.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358868&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 118226871 386398375 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 708298 CC(C)[C@@H](CO)NC(=O)c1ccc2ncc(-c3cc4ccccc4o3)n2n1 InChI=1S/C20H20N4O3/c1-12(2)15(11-25)22-20(26)14-7-8-19-21-10-16(24(19)23-14)18-9-13-5-3-4-6-17(13)27-18/h3-10,12,15,25H,11H2,1-2H3,(H,22,26)/t15-/m1/s1 HQISLAYJOPDUTK-OAHLLOKOSA-N 358869 3-(1-Benzofuran-2-yl)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]imidazo[1,2-b]-pyridazine-6-carboxamide::US10214545, Example 18 Isoform 2 of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1a) 42.0 US Patent 10.7270/Q2833V9N aid1797727 US10214545 Schulze, V; Eis, K; Puehler, F; Zorn, L; Sulzle, D; Lienau, P; Wengner, AM; Petersen, K; Bomer, U Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=358869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=607&target=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=358869&enzyme=Isoform+2+of+MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1+%28MNK1a%29&column=ki&startPg=0&Increment=50&submit=Search 91824175 386398376 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6